Highly efficient, enantioselective syntheses of (S)-(+)- and (R)-(-)-dapoxetine starting with 3-phenyl-1-propanol

Journal of Organic Chemistry

Volumn 75, Issue 1, 2010, Pages 237-240

  Kang, Soyeong ^a   Lee, Hyeon Kyu ^b  

^a Korea Research Institute of Chemical Technology   (South Korea)

^b University of Science and Technology (UST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

1-PROPANOL; ABSOLUTE CONFIGURATION; AMINATION REACTION; CHEMICAL EQUATIONS; DIRHODIUM; ENANTIOSELECTIVE; ENANTIOSELECTIVE SYNTHESIS; SULFAMATES;

ESTERS; RHODIUM;

SYNTHESIS (CHEMICAL);

3 PHENYL 1 PROPANOL; BENZENE DERIVATIVE; DAPOXETINE; FLUOXETINE; PAROXETINE; SERTRALINE; UNCLASSIFIED DRUG;

AMINATION; ARTICLE; CATALYSIS; DRUG SYNTHESIS; ENANTIOSELECTIVITY;

BENZYLAMINES; CATALYSIS; CRYSTALLOGRAPHY, X-RAY; HYDROGEN BONDING; MOLECULAR STRUCTURE; NAPHTHALENES; PROPANOLS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 73449141456     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo902176s     Document Type: Article

References (24)

1. (a) Katzman, M. A. CNS Drug 2009, 23, 103.
2. (b) Preskorn, S. H.; Ross, R.; Stanga, C. Y. In Selective serotonin reuptake inhibitor. Antidepressants: Past, Present, and Future; Preskorn, S. H., Ross, R., Stanga, C. Y., Feighner, J. P., Eds.; Springer-Velarg: Berlin, Germany, 2004, 242.
3. (c) Wong, D. T.; Perry, K. W.; Bymaster, F. P. Nat. Rev. Drug Discovery 2005, 4, 764.
4. (d) Wong, D. T.; Bymaster, F. P.; Engleman, E. A. Life Sci. 1995, 57, 411.
5. (e) Anderson, I. M. J. Affective Disord. 2000, 58, 19.
6. (f) Cipriani, A.; Furukawa, T. A.; Salanti, G.; Geddes, J. R.; Higgins, J. P. T.; Churchill, R.; Watanabe, N.; Nakagawa, A.; Omori, I. M.; McGuire, H.; Tansella, M.; Barbui, C. Lancet 2009, 373, 746.
7. Kendirci, M.; Salem, E.; Hellstrom, W. J. G. Ther. Clin. Risk Manag. 2007, 3, 277.
8. Hellstrom, W. J. G. Neuropsychiatr. Dis. Treat. 2009, 5, 37.
9. Agranat, I.; Caner, H.; Caldwell, J. Nat. Rev. Drug Discovery 2002, 1, 753.
10. Robertson, D. W.; Wong, D. T.; Thompson, D. C. U.S. Patent 5 135 947, 1992.
11. Sorbera, L. A.; Castaner, J.; Castaner, R. M. Drugs Future 2004, 29, 1201.
12. (a) Torre, O.; Gotor-Fernadez, V.; Gotor, V. Tetrahedron: Asymmetry 2006, 17, 860.
13. (b) Fadnavis, N. W.; Radhika, K. R.; Vedamayee Devi, A. Tetrahedron: Asymmetry 2006, 17, 240.
14. Wheeler, W. J.; O'Bannon, D. D. J. Labelled Compd. Radiopharm. 1992, XXXI, 305.
15. Siddiqui, S. A.; Srinivasan, K. V. Tetrahedron: Asymmetry 2007, 18, 2099.
16. Venkatesan, K.; Srinivasan, K. V. ARKIVOC 2008, xvi, 302.
17. Chincholkar, P. M.; Kale, A. S.; Gumaste, V. K.; Deshmukh, A. R. A. S. Tetrahedron 2009, 65, 2605.
18. (a) Zalatan, D. N.; Du Bois, J. J. Am. Chem. Soc. 2008, 130, 9220.
19. (b) Espino, C. G.; Wehn, P. M.; Chow, J.; Du Bois, J. J. Am. Chem. Soc. 2001, 123, 6935.
20. (S)-3-Amino-3-phenylpropan-1-ol (98% ee, 95%) was purchased from Acros Organics (http://www.acros.com), Catalog No. 36217.
21. Tse, M. K.; Bhor, S.; Klawonn, M.; Anilkumar, G.; Jiao, H.; Dobler, C.; Spannenberg, A.; Magerlein, W.; Hugl, H.; Beller, M. Chem. - Eur. J. 2006, 12, 1855.
22. Maguire, M. P.; Feldman, P. L.; Rapoport, H. J. Org. Chem. 1990, 55, 948.
23. (a) Thompson, A. L.; Watkin, D. J. Tetrahedron: Asymmetry 2009, 20, 712.
24. (b) Flack, H. D.; Bernardinelli, G. Chirality 2008, 20, 681.